David Rodman
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
David M.
Rodman is currently a Member-Editorial Board at American Thoracic Society, Inc. and Chief Medical Officer at Mineralys Therapeutics, Inc. since 2021.
Former roles include Vice President-Clinical Development at Vertex Pharmaceuticals, Inc. from 2011 to 2014; Executive Vice President-Research & Development at miRagen Therapeutics, Inc.; Professor at The University of Colorado; Head-Respiratory Translational Medicine at Novartis Institutes for Biomedical Research, Inc.; Chief Medical Officer & Executive VP-Discovery at Nivalis Therapeutics, Inc. from 2016 to 2017; and Executive Vice President-Research & Development at ProQR Therapeutics NV.
Education includes a doctorate from the University of Pennsylvania in 1980 and an undergraduate degree from Haverford College in 1976.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2026 | 57 095 ( 0,08 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Directeur Technique/Scientifique/R&D | 15/01/2017 |
| VERTEX PHARMACEUTICALS INCORPORATED | Directeur Technique/Scientifique/R&D | 01/04/2014 |
| PROQR THERAPEUTICS N.V. | Directeur Technique/Scientifique/R&D | - |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haverford College
Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Commercial Services |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national